English French German Italian Portuguese Russian Spanish

MICUA Matters Newsletter

MICUA Institutions Form Partnership for Student and State Health

Summer 2017


Through a collaboration between MICUA and Adapt Pharma, the maker of NARCAN® Nasal Spray, thirteen independent colleges and universities in Maryland will have access to life-saving medication to treat known or suspected opioid overdoses. MICUA institutions that partner with Adapt Pharma will receive eight free applications of the overdose-reversing drug.

“Colleges must be prepared to respond to every emergency,” said Roger Casey, Chair of the MICUA Board and President of McDaniel College. “While I hope we never need to use NARCAN®, I recognize the need for a comprehensive and proactive response to the opioid epidemic, which must include education, training, counseling, and life-saving medicine.”

In March, Governor Larry Hogan declared a state of emergency in response to the opioid-addiction crisis in Maryland; and in April, the Governor signed legislation enacted by the Maryland General Assembly requiring all institutions of higher education that receive State funds to obtain and store naloxone and adopt opioid prevention plans.

“Maryland’s independent colleges and universities are committed to the welfare of their students, the safety of the campus community, and the overall health of the State,” said Tina Bjarekull, President of MICUA. “This partnership will assist the MICUA member institutions in keeping these commitments and complying with the recently enacted legislation.”

MICUA’s thirteen State-aided member institutions serve the educational, social, and cultural needs of the State and work in partnership with Maryland’s public universities and community colleges on many issues such as the opioid crisis.